相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of novel leukemia mutations (K75E & E222K) on interferon regulatory factor 1 and its interaction with DNA: insights from molecular dynamics simulations and docking studies
Balu Kamaraj et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia
Yu Zhang et al.
CANCER GENE THERAPY (2020)
FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
Hitoshi Kiyoi et al.
CANCER SCIENCE (2020)
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen et al.
CELL (2019)
Prioritization of SNPs in y+LAT-1 culpable of Lysinuric protein intolerance and their mutational impacts using protein-protein docking and molecular dynamics simulation studies
Chandrasekhar Gopalakrishnan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Exploring the functional impact of mutational drift in LRRK2 gene and identification of specific inhibitors for the treatment of Parkinson disease
Nagasundaram Nagarajan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations
Takeshi Yamaura et al.
BLOOD (2018)
Two patients with Canavan disease and structural modeling of a novel mutation
Osama K. Zaki et al.
METABOLIC BRAIN DISEASE (2017)
The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia
Amir T. Fathi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants
Osama K. Zaki et al.
HUMAN MOLECULAR GENETICS (2017)
Molecular Dynamics Validation of Crizotinib Resistance to ALK Mutations (L1196M and G1269A) and Identification of Specific Inhibitors
Nagasundaram Nagarajan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
Maria Larrosa-Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The Future of Targeting FLT3 Activation in AML
Mark B. Leick et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis
Catherine C. Smith et al.
BLOOD (2017)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
FLT3 Inhibitors for Treating Acute Myeloid Leukemia
Mona Hassanein et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Molecularly targeted therapy in acute myeloid leukemia
Harinder Gill et al.
FUTURE ONCOLOGY (2016)
Mutational Analysis on Membrane Associated Transporter Protein (MATP) and Their Structural Consequences in Oculocutaeous Albinism Type 4 (OCA4)A Molecular Dynamics Approach
Balu Kamaraj et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Secondary mutations as mediators of resistance to targeted therapy in leukemia
Naval Daver et al.
BLOOD (2015)
FLT3 D835 mutations confer differential resistance to type II FLT3 inhibitors
C. C. Smith et al.
LEUKEMIA (2015)
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 Gatekeeper F691L Mutation with PLX3397
Catherine C. Smith et al.
CANCER DISCOVERY (2015)
UniProt: a hub for protein information
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2015)
Crystal Structure of the FLT3 Kinase Domain Bound to the Inhibitor Quizartinib (AC220)
Julie A. Zorn et al.
PLOS ONE (2015)
Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study
Balu Kamaraj et al.
PLOS ONE (2015)
Computational Screening of Disease-Associated Mutations in OCA2 Gene
Balu Kamaraj et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations
Sabine Kayser et al.
LEUKEMIA & LYMPHOMA (2014)
Contribution of hydrogen bonds to protein stability
C. Nick Pace et al.
PROTEIN SCIENCE (2014)
Investigation of Binding Phenomenon of NSP3 and p130Cas Mutants and Their Effect on Cell Signalling
K. Balu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
Michael R. Grunwald et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
In Silico Screening and Molecular Dynamics Simulation of Disease-Associated nsSNP in TYRP1 Gene and Its Structural Consequences in OCA3
Balu Kamaraj et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
Cheuk Him Man et al.
BLOOD (2012)
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Catherine C. Smith et al.
NATURE (2012)
An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment
Tiziana Grafone et al.
ONCOLOGY REVIEWS (2012)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Drug resistance in mutant FLT3-positive AML
E. Weisberg et al.
ONCOGENE (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
I-TASSER server for protein 3D structure prediction
Yang Zhang
BMC BIOINFORMATICS (2008)
Radius of gyration as an indicator of protein structure compactness
M. Yu. Lobanov et al.
MOLECULAR BIOLOGY (2008)
ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins
Markus Wiederstein et al.
NUCLEIC ACIDS RESEARCH (2007)
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation
Hitoshi Kiyoi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis
M Yanada et al.
LEUKEMIA (2005)
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
RM Stone et al.
BLOOD (2005)
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain
J Griffith et al.
MOLECULAR CELL (2004)
Novel FLT3 tyrosine kinase inhibitors
M Levis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics:: a study of the AML Study Group Ulm
S Fröhling et al.
BLOOD (2002)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia
CL Sawyers
CANCER CELL (2002)
The Protein Data Bank
HM Berman et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
T Naoe et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation
D Chasman et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Steepest descent methods for multicriteria optimization
J Fliege et al.
MATHEMATICAL METHODS OF OPERATIONS RESEARCH (2000)
分享论文
